SAREPTA THERAPEUTICS INC - DBCV 1.500%11/1

Historical Portfolio Holders from Q4 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / DBCV 1.500%11/1
Principal, excl. options Q3 2024
59.1M
Holdings value Q3 2024
$101M
Value change Q3 2024
-$98.8K
Grand Portfolio weight change Q3 2024
0%
Number of holders
17
Number of buys Q3 2024
3
Number of sells Q3 2024
-3
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $59.1M $101M -$98.8K $1.70 17
2024 Q2 $58.8M $127M -$1.89M $2.15 17
2024 Q1 $62.1M $111M -$643K $1.79 19
2023 Q4 $63.1M $89.4M -$2.41M $1.42 23
2023 Q3 $63.4M $113M +$749K $1.77 20
2023 Q2 $63.6M $108M +$10.2M $1.69 24
2023 Q1 $55.6M $108M -$599M $1.94 24
2022 Q4 $375M $701M +$15M $1.87 38
2022 Q3 $377M $630M -$162M $1.67 37
2022 Q2 $513M $647M -$50.8M $1.26 36
2022 Q1 $550M $724M +$4.27M $1.31 38
2021 Q4 $554M $811M -$3.83M $1.46 36
2021 Q3 $557M $828M +$15.9M $1.48 42
2021 Q2 $544M $720M -$16.2M $1.32 39
2021 Q1 $559M $731M -$104M $1.31 39
2020 Q4 $538M $1.32B +$13.3M $2.45 45
2020 Q3 $528M $1.09B +$33.6M $2.07 41
2020 Q2 $509M $1.17B +$4.02M $2.30 44
2020 Q1 $521M $801M +$3.18M $1.52 41
2019 Q4 $511M $1.01B +$19.6M $1.95 38
2019 Q3 $536M $710M +$27.3M $1.32 37
2019 Q2 $501M $1.12B -$55.8M $2.23 42
2019 Q1 $521M $941M +$861M $1.80 39
2018 Q4 $44.1M $73.9M +$73.9M $1.68 1